Last reviewed · How we verify
NCT07077915
Osseodensification vs Conventional Drilling for Immediate Dental Implant Placement
NA trial testing Osseodensification burs in Immediate Dental Implant Placement in 24 participants. Enrolling by invitation.
23 December 2025
Quick facts
| Lead sponsor | Mohamad Ali Itani |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 1 July 2025 |
| Primary completion | 23 December 2025 |
| Estimated completion | 23 December 2025 |
| Sites | 1 location across Lebanon |
Drugs / interventions tested
- Osseodensification burs
- Conventional burs
Conditions studied
- Immediate Dental Implant Placement — all drugs for Immediate Dental Implant Placement →
- Conventional Drilling Technique — all drugs for Conventional Drilling Technique →
- Osseodensification Drilling Technique — all drugs for Osseodensification Drilling Technique →
Sponsor
Mohamad Ali Itani
Who can join
Adults 25 to 45, any sex, with Immediate Dental Implant Placement or Conventional Drilling Technique. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim of the study is to analyze and compare the characteristic differences occurring in the surrounding bone in an immediate implant placed by osseodensification to immediate implants placed with the conventional technique
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07077915
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07077915 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mohamad Ali Itani
- Last refreshed: 28 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07077915.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing